German insurers puzzled by nursing home issue
This article was originally published in Clinica
Germany's statutory health insurers are nonplussed by a letter sent by the industry association for medical devices (BVMed) to their own leading association, on the subject of their refusal to reimburse medical aids in nursing homes. BVMed said that it had been alerted by its member companies to the fact that the association of the statutory health insurers had advised their individual members against reimbursement.
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.